Cargando…
Fasudil Loaded PLGA Microspheres as Potential Intravitreal Depot Formulation for Glaucoma Therapy
Rho-associated protein kinase (ROCK) inhibitors allow for causative glaucoma therapy. Unfortunately, topically applied ROCK inhibitors suffer from high incidence of hyperemia and low intraocular bioavailability. Therefore, we propose the use of poly (lactide-co-glycolide) (PLGA) microspheres as a de...
Autores principales: | Mietzner, Raphael, Kade, Christian, Froemel, Franziska, Pauly, Diana, Stamer, W. Daniel, Ohlmann, Andreas, Wegener, Joachim, Fuchshofer, Rudolf, Breunig, Miriam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464914/ https://www.ncbi.nlm.nih.gov/pubmed/32727014 http://dx.doi.org/10.3390/pharmaceutics12080706 |
Ejemplares similares
-
Distribution of Gold Nanoparticles in the Anterior Chamber of the Eye after Intracameral Injection for Glaucoma Therapy
por: Sonntag, Tobias, et al.
Publicado: (2021) -
Angiopoietin-1 Mimetic Nanoparticles for Restoring the Function of Endothelial Cells as Potential Therapeutic for Glaucoma
por: Mietzner, Raphael, et al.
Publicado: (2021) -
PLGA Microspheres with Alginate-Coated Large Pores for the Formulation of an Injectable Depot of Donepezil Hydrochloride
por: Kim, Dohyun, et al.
Publicado: (2020) -
Loss of retinal ganglion cells in a new genetic mouse model for primary open‐angle glaucoma
por: Reinehr, Sabrina, et al.
Publicado: (2019) -
Exploring a Novel Fasudil-Phospholipid Complex Formulated as Liposomal Thermosensitive in situ Gel for Glaucoma
por: Khallaf, Aya M, et al.
Publicado: (2022)